lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262)
A2330
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product Namelexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionLexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4kappa type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. MW : 145.5 KD.
- Storage Instruction-20°C
- UNSPSC12352203